Fmoc-Orn-OH · HCl

Fmoc-Orn-OH · HCl is an Fmoc-protected ornithine hydrochloride, featuring an α-amino acid backbone with a protected N-terminus suitable for stepwise peptide assembly and a side-chain primary amine characteristic of ornithine. The salt form (·HCl) provides defined handling of the basic side chain, while the Fmoc carbamate masks the α-amino functionality to control chemoselectivity during coupling. The molecule combines a carboxylic acid for amide bond formation with an Fmoc-protected stereogenic framework, enabling stereochemically consistent incorporation into peptide sequences and subsequent side-chain derivatization. The presence of a free carboxyl group and a protected α-amine architecture makes the compound compatible with standard protected amino acid chemistry and downstream functionalization strategies.

1. Peptide Synthesis

Fmoc-Orn-OH · HCl is used in peptide synthesis for constructing ornithine-containing sequences via standard Fmoc/t-Bu solid-phase or solution-phase coupling workflows. The Fmoc group protects the α-amino position, while the side-chain primary amine remains available for orthogonal protection or controlled post-assembly modification. The carboxylic acid functionality participates in peptide bond formation to generate amide linkages, and the side-chain amine can be retained for cationic residues or selectively protected to avoid cross-reactivity during chain elongation. The resulting ornithine-bearing peptide building blocks support studies of polycationic motifs, receptor-binding elements, and scaffold architectures where side-chain charge distribution matters in peptide science.

2. Side-Chain Functionalization

Fmoc-Orn-OH · HCl is applied in side-chain functionalization and amino acid derivatization to access ornithine derivatives bearing amide, urea, sulfonamide, or other nitrogen-based functionalities at the side chain. The unmasked side-chain primary amine enables targeted coupling to activated esters, carbonyl equivalents, or sulfonylating reagents, while the Fmoc-protected α-amino group supports chemoselective transformations that preserve peptide compatibility. Salt formation with hydrochloride can improve operational reproducibility during derivatization planning by stabilizing the basic amine under preparation conditions. Ornithine-modified intermediates derived from this building block can feed into peptidomimetics, charged biomolecule conjugates, and synthetic organic routes requiring a chiral amino acid scaffold with a functional handle.

3. Bioconjugation Chemistry

Fmoc-Orn-OH · HCl is suitable for bioconjugation chemistry where ornithine side-chain amines act as reactive attachment points for labeling and conjugate construction. The compound's amino acid architecture supports incorporation into peptide carriers or linker segments that can be assembled with defined N-terminal protection logic, then deprotected or transformed to yield conjugation-ready amines. The Fmoc-protected α-amino group helps maintain control over which nitrogen is engaged during coupling steps, supporting orthogonal strategies when preparing linker peptides for biomolecule labeling. Downstream conjugates can be generated for chemical biology workflows such as affinity-tagging constructs, probe-linker design, and modular assembly of functional biomolecule derivatives.

4. Unnatural Amino Acid Incorporation

Fmoc-Orn-OH · HCl is employed in unnatural amino acid incorporation and molecular design workflows to introduce an ornithine residue with a side-chain primary amine into peptide-based libraries and engineered sequences. The defined stereochemistry of the α-amino acid backbone supports consistent chiral presentation in peptide analogs, while the Fmoc group enables systematic placement at specific positions during synthesis. The side-chain amine can be used as a handle for further functionalization, allowing generation of cationic, neutral, or derivatized variants that probe sequence-dependent structure-function relationships. Ornithine-containing analogs prepared from this chiral building block can serve as intermediates for SAR studies, peptidomimetic construction, and combinatorial scaffold generation in applied amino acid chemistry.

5. Pharmaceutical Intermediate Preparation

Fmoc-Orn-OH · HCl is used in pharmaceutical intermediate preparation and process chemistry for manufacturing routes that require Fmoc-protected amino acid building blocks with a reactive side-chain functionality. The carboxylic acid and Fmoc-protected α-amine support reliable amide coupling logic, while the side-chain primary amine enables subsequent conversion into protected or activated nitrogen-containing intermediates used in medicinal chemistry. The hydrochloride salt form can be leveraged to manage basicity during synthesis planning and to support reproducible handling of the amine functionality across multi-step sequences. Downstream utility includes preparation of protected ornithine derivatives, linker segments, and nitrogen-functional intermediates that integrate into larger synthetic programs for fine chemical and pharmaceutical chemistry manufacturing.

1. Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line

2. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

3. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review

4. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction

5. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients